Immune Modulation Therapy May Treat Ovarian Cancer
- By BSTQ Staff
Researchers from the Royal Women’s Hospital and Monash University in Melbourne, Australia, are testing immune modulation therapy to treat ovarian cancer. The therapy works on the theory that the immune system has a 10- to 14-day cycle during which it emits “inhibitor cells” that stop the body from fighting cancer. By giving small, tightly targeted chemotherapy doses at exactly the right time in the cycle, the inhibitor cells are blocked and the body’s defense against the tumor is boosted. The chemotherapy comes in a pill that is taken every two weeks. Patients also must have a blood test every two days. To date, seven women with advanced, recurrent ovarian cancer have been given the therapy, and several have responded positively.